AbbVie Inc.
ABBV
$225.11
-$2.59-1.14%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -80.17% | -27.06% | 5,945.45% | -101.41% | 13.94% |
| Total Depreciation and Amortization | 0.63% | 0.54% | -3.00% | 1.11% | -2.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 29.15% | 206.40% | -83.41% | 407.57% | -50.88% |
| Change in Net Operating Assets | 322.95% | 78.22% | -549.87% | -152.93% | 122.18% |
| Cash from Operations | 36.31% | 215.17% | -76.80% | 29.39% | 139.85% |
| Capital Expenditure | -41.64% | -14.47% | 19.24% | -16.87% | -3.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -198.09% | -74.72% | 69.98% | 78.90% | -907.47% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -389.29% | -26.32% | -81.82% | -57.00% | 2,800.00% |
| Cash from Investing | -176.38% | -60.68% | 60.78% | 77.30% | -649.18% |
| Total Debt Issued | -93.92% | -29.07% | 179.35% | -- | -- |
| Total Debt Repaid | 46.30% | -24.06% | 47.48% | -1,329.78% | 87.96% |
| Issuance of Common Stock | 1,160.00% | -91.07% | 460.00% | -85.07% | 570.00% |
| Repurchase of Common Stock | 66.67% | 98.75% | -168.44% | -2,005.88% | -88.89% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.03% | 0.51% | -6.29% | -0.04% | -0.04% |
| Other Financing Activities | 1,950.00% | -118.18% | 1,000.00% | -96.88% | -- |
| Cash from Financing | -69.37% | -115.42% | 81.66% | -123.34% | 49.61% |
| Foreign Exchange rate Adjustments | -126.67% | 233.33% | 119.57% | -675.00% | 188.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -164.86% | 470.20% | 79.86% | 70.49% | -18.96% |